APA (7th ed.) Citation

Yabe, D., Yasui, A., Ji, L., Lee, M., Ma, R. C. W., Chang, T., . . . Seino, Y. (2019). Safety and tolerability of empagliflozin in East Asian patients with type 2 diabetes: Pooled analysis of phase I–III clinical trials. Journal of diabetes investigation, 10(2), 418-428. https://doi.org/10.1111/jdi.12910

Chicago Style (17th ed.) Citation

Yabe, Daisuke, et al. "Safety and Tolerability of Empagliflozin in East Asian Patients with Type 2 Diabetes: Pooled Analysis of Phase I–III Clinical Trials." Journal of Diabetes Investigation 10, no. 2 (2019): 418-428. https://doi.org/10.1111/jdi.12910.

MLA (9th ed.) Citation

Yabe, Daisuke, et al. "Safety and Tolerability of Empagliflozin in East Asian Patients with Type 2 Diabetes: Pooled Analysis of Phase I–III Clinical Trials." Journal of Diabetes Investigation, vol. 10, no. 2, 2019, pp. 418-428, https://doi.org/10.1111/jdi.12910.